Noriyuki Namiki

Faculty of Pharmaceutical Sciences,Department of Pharmaceutical SciencesProfessor
Graduate School of Pharmaceutical Sciences,Doctoral Program in Pharmaceutical SciencesProfessor
Last Updated :2025/10/07

■Researcher basic information

Degree

  • Ph.D., Tokyo University of Pharmacy and Life Sciences, Mar. 1998

Research Keyword

  • IoT technology
  • Formulation Design
  • Gummi Drugs
  • Flavor
  • Bitterness Masking
  • Clinical Functionality
  • Medication Adherence
  • Oral Disintegrating Tablet
  • Clinical Pharmaceutical Science
  • Pharmaceutical Science

Field Of Study

  • Life sciences, Clinical pharmacy, Clinical Pharmaceutical Science

■Career

Career

  • Apr. 2021 - Present
    University of Shizuoka
  • Apr. 2021 - Present
    University of Shizuoka
  • Apr. 2021 - Present
    Teikyo Heisei University, Faculty of Pharmaceutical Sciences
  • Apr. 2008 - Mar. 2021
    University of Shizuoka, School of Pharmaceutical Sciences
  • Oct. 1991 - Mar. 2008
  • Apr. 1979 - Sep. 1991

Educational Background

  • Apr. 1975 - Mar. 1979, Tokyo University of Pharmacy and Life Sciences, School of Pharmacy

Member History

  • Mar. 2017 - Present
  • Mar. 2017 - Mar. 2021
  • May 2017 - Jun. 2018

■Research activity information

Award

  • Apr. 2021
  • May 2014
  • May 2006

Paper

  • Effects of Flavors on Taste Sensation of Pioglitazone Orally               
    Yoshinori Nakano; Motoyasu Miura; Noriyuki Namiki; Shinya Uchida
    Chem. Pharm. Bull., Nov. 2024, [Reviewed]
  • Palatability evaluation of orally disintegrating tablets using a visual analog scale in clinical trials               
    Motoyasu Miura; Seiki Kojima; Shimako Tanaka; Yasuharu Kashiwagura; Noriyuki Namiki; Shinya Uchida
    International Journal of Clinical Pharmacology and Therapeutics, Aug. 2024, [Reviewed]
  • 内炎予防及び治療を目的とした院内製剤アロプリノール及びポラプレジンクフォーム製剤の開発)               
    May 2024, [Reviewed]
  • Development of an on-site therapeutic drug monitoring method using a portable spectrometer               
    Kenichiro Todoroki; Nan Fukudo; Yuto Kudoh; Hajime Mizuno; Jun Zhe Min; Shimako Tanaka; Shinya Uchida; Noriyuki Namiki; Toshimasa Toyo’oka
    Analytical Sciences, Jan. 2024, [Reviewed]
  • Improved palatability of gummy drugs of epinastine hydrochloride using organoleptic taste-masking methods               
    Shimako Tanaka; Sayuri Kawamoto; Yasuharu Kashiwagura; Akio Hakamata; Keiichi Odagiri; Takashi Okura; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki; Shinya Uchida
    Chem. Pharm. Bull. Report, Nov. 2023, [Reviewed]
  • Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods               
    Yasuharu Kashiwagura; Shota Takusagawa; Yasuyuki Ikematsu; Shimako Tanaka; Noriyuki Namiki; Shinya Uchida
    ACTA PHARMACEUTICA, Jul. 2023, [Reviewed]
  • Palatability of aripiprazole gummies prepared from commercially available products:pharmaceutical formulation for improving patient adherence               
    Sayuri Kawamoto; Shimako Tanaka; Motoyasu Miura; Yasuharu Kashiwagura; Chiaki Kamiya; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki; Shinya Uchida
    Chem. Pharm. Bull, Apr. 2023, [Reviewed]
  • 乳児血管腫治療を目的とした院内製剤・プロプラノロールクリームの調製および製剤学的評価               
    Aug. 2022, [Reviewed]
  • Topical formulations of propranolol for infantile hemangiomas: characteristics of formulations and three cases of infants administered topical propranolol cream.               
    Yasuharu Kashiwagura; Akio Hakamata; Masami Shirai; Akira Endoh; Shimako Tanaka; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki; Shinya Uchida
    Chem. Pharm. Bull, Jan. 2022, [Reviewed]
  • Increased plasma drug concentration and decreased additional insulin secretion following oral administration of glimepiride in Spontaneously Diabetic Torii rats.               
    M. Miura; S. Tanaka; M. Ikeda; J. Kawakami; H. Watanabe; N. Namiki; S. Uchida
    Pharmazie, Nov. 2021, [Reviewed]
  • Impact of community pharmacist-led intensive education on the control of serum phosphate levels in haemodialysis patients               
    Hiroshi Suzuki; Shinya Uchida; Yasuharu Kashiwagura; Shimako Tanaka; Katsuya Yamauchi; Shinji Kageyama; Noriyuki Namiki
    Int J Clin Pharm., Jul. 2021, [Reviewed]
  • Prediction of the area under the curve using limited-point blood sampling in a cocktail study to asses multiple CYP activities.               
    Motoyasu Miura; Shimako Tanaka; Shinya Uchida; Chiaki Kamiya; Naoki Katayama; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Junichi Kawakami; Hiroshi Watanabe; Noriyuki Namiki
    Bio. Pharm. Bull, Jun. 2021, [Reviewed]
  • Gummi formulations comprising amenamevir solid dispersions with polyvinyl alcohol.               
    Shimako Tanaka; Atsushi Kambayashi; Koki Sugimoto; Yasuharu Kashiwagura; Noriyuki Namiki; Shinya Uchida
    Chem. Pharm. Bull, May 2021, [Reviewed]
  • Evaluation of disappearance time and palatability of foams in the oral cavities of healty volunteers, and preparation of drug-containing foam formulations for use in the treatment of oral mucositis.               
    Marina Oshiro-Sembokuya; Shinya Uchida; Yasuharu Kashiwagura; Maika Ashihara; Shimako Tanaka; Takao Hashimoto; Chiyo Kokubu; Noriyuki Namiki
    Chem. Pharm. Bull., Apr. 2021, [Reviewed]
  • Verification of a cocktail approach for quantitative drug-drug interaction assessment: a comparative analysis between the results of a single drug and a cocktail drug.               
    Motoyasu Miura; Shinya Uchida; Shimako Tanaka; Chiaki Kamiya; Naoki Katayama; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Junichi Kawakami; Hiroshi Watanabe; Noriyuki Namiki
    Xenobiotica, Apr. 2021, [Reviewed]
  • Clinical evaluation of drug-drug interactions between the cytochrome P450 substrates selexipag and clopidogrel in Japanese volunteers.               
    Naoki Katayama; Keiichi Odagiri; Akio Hakamata; Chiaki Kamiya; Shinya Uchida; Shimako Tanaka; Naoki Inui; Noriyuki Namiki; Koichiro Tatsumi; Hiroshi Watanabe
    Br J Clin Pharmaco, Apr. 2021, [Reviewed]
  • In vitro transdermal permeation and in vivo transdermal absorption of domperidone cream formulations compounded from tablets as a hospital formulation.               
    Y. Kashiwagura; S. Uchida; A. Hakamata; H. Watanabe; N. Namiki
    PHARMAZIE, Jan. 2021, [Reviewed]
  • Combining powder formulations of drugs with food and beverages to improve palatability               
    Shimako Tanaka; Shinya Uchida; Mai Sotoyama; Yasuharu Kashiwagura; Noriyuki Namiki
    Bio. Pharm. Bull., Sep. 2020, [Reviewed]
  • Morphological evaluation of low-dose midazolam granules by laser Raman microscopy               
    Imoto J.; Uchid S.; Kashiwagura Y.; Tanaka S.; Namiki N.
    Int. J. Pharm., Sep. 2020, [Reviewed]
  • Sustained impact of community pharmacist-led intensive education on the management of serum phosphate levels in patients receiving haemodialysis               
    Hiroshi Suzuki; Shinya Uchida; Yasuharu Kashiwagura; Shimako Tanaka; Katsuya Yamauchi; Shinji Kageyama; Noriyuki Namiki
    International Journal of Clinical Pharmacy, Aug. 2020, [Reviewed]
  • Evaluation of weight variation in mini-tablets manufactured by a multiple-tip tool               
    Homare Kurashima; Shinya Uchida; Yasuharu Kashiwagura; Shimako Tanaka; Noriyuki Namiki
    Chem. Pharm. Bull., Jul. 2020, [Reviewed]
  • Evaluation of in vitro and in vivo transdermal absorption of solifenacin succinate               
    Mitsunobu Yoshida; Shinya Uchida; Yasuharu Kashiwagura; Shimako Tanaka; Rakan Matsui; Noriyuki Namiki
    Chem. Pharm. Bull., Nov. 2019, [Reviewed]
  • An effective polyvinyl alcohol for the solubilization of poorly water-soluble drugs in solid dispersion formulations               
    Yoshiaki Umemoto; Shinya Uchida; Takatsune Yoshida; Ken Shimada; Hiroyuki Kojima; Akira Takagi; Shimako Tanaka; Yasuhiro Kashiwagura; Noriyuki Namiki
    Journal of Drug Delivery Science and Technology, Nov. 2019, [Reviewed]
  • 口腔内崩壊錠に必要とされる臨床製剤学的特性とミチグリニド・ボグリボース配合口腔内崩壊錠(グルベス配合OD錠)の製剤検討               
    Sep. 2019, [Reviewed]
  • The prediction of the area under the curve and clearance of midazolam from single-point plasma concentration and urinary excretion in healthy volunteers               
    Motoyasu Miura; Shinya Uchida; Shimako Tanaka; Naoki Inui; Junichi Kawakami; Hiroshi Watanabe; Noriyuki Namiki
    Bio. Pharm. Bull., Sep. 2019, [Reviewed]
  • Ease of taking and palatability of fixed-dose orally disintegrating mitiglinide/voglibose tablets               
    Mai Sotoyama; Shinya Uchida; Chiaki Kamiya; Shimako Tanaka; Yasuharu Kashiwagura; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    Chem. Pharm. Bull., Jun. 2019, [Reviewed]
  • クレメジン速崩錠を服用中の患者における服用性アンケート調査とその評価               
    Jan. 2019, [Reviewed]
  • Preparation of cocoa powder-containing orally disintegrating tablets of rebamipide (rebamipide chocolet) and evaluation of their clinical palatability               
    Hidehiko Takano; Shinya Uchida; Yasuharu Kashiwagura; Shimako Tanaka; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    Chem. Pharm. Bull., Jan. 2019, [Reviewed]
  • In vivo drug dissolution in human oral cavity from orally disintegrating tablet and comparability with in vitro testing               
    Tsuyoshi Katayama; Shinya Uchida; Chinaki Kamiyama; Shimako Tanaka; Yasuharu Kashiwagura; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    Chem. Pharm. Bull., Oct. 2018, [Reviewed]
  • Palatability and preference of gummi formulation with various pharmaceutical characteristics               
    Fumiaki Nakagaki; Shinya Uchida; Shimako Tanaka; Noriyuki Namiki
    Chem. Pharm. Bull., Apr. 2018, [Reviewed]
  • Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats               
    Osamu Yasumuro; Shinya Uchida; Yasuharu Kashiwagura; Ayae Suzuki; Shimako Tanaka; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    Xenobiotica, Oct. 2017, [Reviewed]
  • Citric acid suppresses the bitter taste of olopatadine hydrochloride orally disintegrating tablets               
    Mai Sotoyama; Shinya Uchida; Shimako Tanaka; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    Bio. Pharm. Bull., Apr. 2017, [Reviewed]
  • 錠剤の新規包装容器(服薬支援容器)の使用性の評価               
    Apr. 2017, [Reviewed]
  • Orally sustained-release suspension based on a lauryl sulfate salt/complex               
    Yuuki Kasashima; Shinya Uchida; Keiichi Yoshihara; Takehiko Yasuji; Kazuhiro Sako; Noriyuki Namiki
    Int. J. Pharm., Oct. 2016, [Reviewed]
  • Oral sustained release of a hydrophilic drug using the lauryl sulfate salt/complex               
    Yuuki Kasashima; Keiichi Yoshihara; Takehiko Yasuji; Kazuhiro Sako; Shinya Uchida; Noriyuki Namiki
    Chem. Pharm. Bull., Sep. 2016, [Reviewed]
  • Imporved palatability of orally disintegrating tablets of mitiglinide calcium hydrate (GUFAST OD) by combined masking of organoleptic taste and physical taste, and assessment of clinical pharmaceutics               
    Shinya Uchida; Yasuharu Kashiwagura; Mai Sotoyama; Shimako Tanaka; Shota Takusagawa; Akio Hakamata; Keiichi Odagiri; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    Apr. 2016, [Reviewed]
  • シロドシン口腔内崩壊錠(ユリーフOD錠)の臨床製剤学的評価               
    Dec. 2015, [Reviewed]
  • The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system               
    Hideshi Nakamura; Shinya Uchida; Takeshi Sugiura; Noriyuki Namiki
    Int. J. Pharm., Jul. 2015, [Reviewed]
  • Development of gummi drugs of aripiprazole as hospital formulations               
    Shinya Uchida; Shogo Hiraoka; Noriyuki Namiki
    Chem. Pharm. Bull., May 2015, [Reviewed]
  • Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug               
    Yasuyuki Ikematsu; Shinya Uchida; Noriyuki Namiki
    Chem. Pharm. Bull., Mar. 2015, [Reviewed]
  • Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets               
    Kimura; Shinya Uchida; Ken Kanada; Noriyuki Namiki
    Int. J. Pharm., Feb. 2015, [Reviewed]
  • Preparation and evalution of highly drug-loaded fine globular granules using a multi-functional rotor processor               
    Yasunori Iwao; Shin-ichiro Kimura; Masayuki Ishida; Ryohei Mise; Masaki Yamada; Noriyuki Namiki; Shuji Noguchi; Shigeru Itai
    Chem. Pharm. Bull., Feb. 2015, [Reviewed]
  • 次世代型口腔内崩壊錠に求められる臨床的機能性とは?               
    Jan. 2015
  • Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability               
    Rakan Matsui; Shinya Uchida; Noriyuki Namiki
    Bio. Pharm. Bull.Vol., Jan. 2015, [Reviewed]
  • In vitro and in vivo evaluation under finite conditions of a transdermal oil-in-water type emulsified formulation of propiverine hydrochloride               
    Rakan matsui; Shinya Uchida; Noriyuki Namiki
    Bio. Pharm. Bull., Oct. 2014, [Reviewed]
  • Preparation and characterization of high-content aripiprazole-loaded core-shell structure microsphre for long-release injectable formulation               
    Shogo Hiraoka; Shinya, Uchida; Noriyuki Namiki
    Chem. Pharm. Bull., Jul. 2014, [Reviewed]
  • Evaluation of the physicochemical properties of fine globular granules prepared by a multi-functional rotor processor               
    Shin-ichiro Kimura; Yasunori Iwao; Masayuki Ishida; Shuji Noguchi; Shigeru Itai; Shinya Uchida; Masaki Yamada; Noriyuki Namiki
    Chem. Pharm. Bull., Apr. 2014, [Reviewed]
  • Clinical efficacy and pharmacokinetics of levothyroxine suppository in patiens with hypothyroidism               
    Yasuharu Kasiwagura; Shinya Uchida; Shimako Tanaka; Hiroshi Watanabe; Masahiro Masuzawa; Tadanori Sasaki; Noriyuki Namiki
    Bio. Pharm. Bull., Apr. 2014, [Reviewed]
  • Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate durgs and their metabolites               
    Shimako Tanaka; Shinya Uchida; Naoki Inui; Kazuhiko Takeuchi; Hiroshi Watanabe; Noriyuki Namiki
    Bio. Pharm. Bull., Jan. 2014, [Reviewed]
  • Comparison of inhibitory duration of grapefurit juice on organic anion-transporting polypeptide and cytochrome P450 3A4               
    Shimako Tanaka; Shinya Uchida; Sachiko Miyakawa; Naoki Inui; Kazuhiko Takeuchi; Hiroshi Watanabe; Noriyuki Namiki
    Bio. Pharm. Bull., Dec. 2013, [Reviewed]
  • Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healty volunteers               
    Tomohiro Yoshita; Shinya Uchida; Noriyuki Namiki
    Bio. Pharm. Bull., Sep. 2013, [Reviewed]
  • Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healty japanese volunteers, using the cocktail method               
    Tomohiro Yoshita; Shinya Uchida; Noriyuki Namiki
    Clinical Pharmacology & Therapeutics, Sep. 2013, [Reviewed]
  • Pharmaceutical Development of a Parenteral Formulation of Conivaptan Hydrochloride               
    Kazutoshi Ban; Ritsu Sonohara; Mitsunobu Yoshida; Kazuhiro Sako; Sinya Uchida; Noriyuki Namiki
    PDA J Pharm Sci Technol, Aug. 2013, [Reviewed]
  • Reduction in the volume of water for ingesting orally disintegrating tablets of solifenacin (Vesicare® OD), and the clinical disintegration time of Vesicare® OD after unit-dose packaging               
    Shinya Uchida; Tomohiro Yoshita; Noriyuki Namiki
    Int. J. Pharm., Mar. 2013, [Reviewed]
  • Preparation and evalution of unpleasant taste-masked pioglitazone orally disintegrating tablets               
    Yoshinori Nakano; Arisa Maeda; Shinya Uchida; Noriyuki Namiki
    Int. J. Pharm., Feb. 2013, [Reviewed]
  • Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans               
    Tsutomu Kotegawa; Kimiko Tsutsumi; Hajime Morita; Hiromitsu, Imai; Misaki Morita; Tsuneaki Yoshizato; Tetsuji Oyama; Shinya Uchida; Hiroshi Watanabe; Noriyuki Namiki; Kiyoichi Ohashi
    Eur J Clin Pharmacol, Oct. 2012, [Reviewed]
  • Influence of Different Proton Pump Inhibitors on Activity of Cytochrome P450 Assessed by [13C]-Aminopyrine Breath Test.               
    Kodaira C.; Uchida S.; Yamade M.; Nishino M.; Ikuma M.; Namiki N.; Sugimoto M.; Watanabe H.; Hishida A.; Furuta T.
    J Clin Pharmacol., May 2012, [Reviewed]
  • aste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.               
    Sugiura T.; Uchida S.; Namiki N.
    Chem. Pharm. Bull., Mar. 2012, [Reviewed]
  • 地域医療を支え、薬剤師の意欲を高めるリカレント教育と大学の役割               
    Nov. 2011
  • Formulation Study for Orally Disintegrating Tablet Using Partly Pregelatinized Starch Binder               
    Kazuki Mimura; Ken Kanada; Shinya Uchida; Masaki Ymada; Noriyuki Namiki
    Chem. Pharm. Bull., Aug. 2011, [Reviewed]
  • Usefulness of Drug Information Websites Accessed by Cell Phone Using Two-dimensional Matrix Barcordes               
    Tatsumi Kawai; Shinya Uchida; Noriyuki Namiki
    Jpn. J. Pharm. Health Care Sci., Apr. 2011, [Reviewed]
  • アムロジピンOD錠「ケミファ」の臨床使用における錠剤物性               
    Mar. 2011, [Reviewed]
  • Onset of clinical effects and plasma concentration of fluvoxamine in japanese patients               
    Katoh Y.; Uchida S.; Kawai M.; Takei N.; Mori N.; Kawakami Y.; Kagawa Y.; Yamada S.; Namiki N.; Hashimoto H.
    Biol. Pharm. Bull., Dec. 2010, [Reviewed]
  • Effect of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients.               
    Katoh Y.; Uchida S.; Kawai M.; Takei N.; Mori N.; Kawakami Y.; Yamada S.; Namiki N.; Hashimoto H.
    Biol. Pharm. Bull., Feb. 2010, [Reviewed]
  • 臨床が求める製剤技術、粒子設計の進歩は口腔内崩壊錠の進歩               
    Dec. 2009
  • ピンポイント麻酔剤・リドカインスティックの製剤化と臨床評価               
    Jul. 2009, [Reviewed]
  • チョコレート風味の口腔内速崩錠 (チョコレット) の開発に関する研究(第3報)―患者ベネフィットの向上を目指したレバミピドチョコレット調製条件の最適化―               
    Aug. 2007, [Reviewed]
  • セイフティマネジメントをめざした病棟薬剤師1日常駐の試行とその評価               
    Nov. 2005, [Reviewed]
  • ニトロール注バッグの臨床における有用性の評価               
    Jul. 2005, [Reviewed]
  • チョコレート風味の口腔内速崩錠・チョコレットの開発に関する研究(第2報)、直接圧縮打錠法を用いたレバミピドチョコレットの調製               
    May 2005, [Reviewed]
  • チョコレート風味の口腔内速崩錠・チョコレットの開発に関する研究、チョコレットプラセボ錠の調製と錠剤物性               
    May 2004, [Reviewed]
  • 口腔内速崩錠の全自動錠剤分包機による調剤の適否               
    Apr. 2004, [Reviewed]
  • 小児向け剤形の開発に関する研究(第8報)酸性、および中性グミベースを用いたグミ製剤の調製               
    Jan. 2003, [Reviewed]
  • 小児向け剤形の開発に関する研究(第7報)グミ製剤における基剤成分の結晶析出抑制               
    Mar. 2002, [Reviewed]
  • Studies on development of dosage forms for pediatric use (Ⅴ), oral mucosal irritation study of gummi drugs in hamster cheek pouch.               
    Namiki N.; Takagi N.; Yuasa H.; Kanaya Y.
    Biol. Pharm., Jan. 1998, [Reviewed]
  • グミ製剤からのアセトアミノフェンの放出性               
    Apr. 1997, [Reviewed]
  • Studies on development of dosage form for pediatric use (No. 4), Time course of plasma concentration of acetaminophen after oral administration of gummi drug and powder preparation in dogs               
    Namiki N.; Takagi N.; Yuasa H.; Kanaya H.
    Yakuzaigaku, Apr. 1997, [Reviewed]
  • グミ製剤の保存安定性               
    Mar. 1997, [Reviewed]
  • ゼラチンを用いたグミ製剤の調製               
    Feb. 1997, [Reviewed]
  • Studies on development of pharmaceutical preparations prescribed in hospitals. Ⅵ. Oxaprozin nasal spray               
    Namiki N.; Yokoyama H.; Fukuda Y.; Takashima T.; Uchida Y.; Ozawa M.; Yuasa H.; Kanaya Y.
    Drug Design and Delivery, Feb. 1988, [Reviewed]
  • Studies on development of pharmaceutical preparations prescribed in hospitals. Ⅲ. Prevention of fading by use of solid dispersion system of ointment containing               
    Namiki N.; Yokoyama H.; Moriya K.; Sakakura M.; Takashima T.; Yuasa H.; Kanaya Y.
    Chem. Pharm. Bull., Feb. 1986, [Reviewed]
  • Studies on development of pharmaceutical preparations prescribed in hospitals. Ⅴ. Nifedipine hollow type suppository               
    Namiki N.; Yokoyama H.; Moriya K.; Fukuda Y.; Takashima T.; Tamura H.; Yuasa H.; Kanaya Y.
    Drug Design and Delivery, Jan. 1986, [Reviewed]
  • 院内処方散剤の結晶セルロース添加による錠剤化               
    Apr. 1984, [Reviewed]

Books and other publications

  • 基礎と臨床をつなぐ 物理薬剤学・製剤学               
    Joint work
    Mar. 2023
  • 医薬品添加剤における開発および製剤設計・評価の新展開               
    Joint work
    Apr. 2022
  • すべてがわかる口腔内崩壊錠ハンドブックー製剤技術・装置・添加剤偏ー(PLCM(耕薬)研究会編集)               
    Joint work
    Feb. 2020
  • 医薬品製剤開発のための次世代微粒子コーティング技術               
    Joint work
    Dec. 2012
  • 新しい薬学辞典               
    Joint work
    Jun. 2012
  • すべてがわかる口腔内崩壊錠ハンドブック(PLCM(耕薬)研究会編集)               
    Joint work
    Jan. 2012
  • 製剤化のサイエンス               
    Joint work
    Mar. 2010
  • 薬剤師による手術室の薬剤管理マニュアル               
    Joint work
    Oct. 2008
  • 病院薬局製剤・第6版(日本病院薬剤師会偏)               
    Joint work
    Aug. 2008
  • 医薬品製剤化方略と新技術               
    Joint work
    Mar. 2007
  • 病院薬局製剤・5版(日本病院薬剤師会偏)               
    Joint work
    Jul. 2005
  • 薬学生・実習指導者のための実務実習ガイドブック               
    Joint work
    Jul. 2005
  • 改訂版薬学生病院実習テキスト               
    Joint work
    May 2001
  • 臨床薬物治療学               
    Joint work
    Apr. 2000
  • 薬学生病院実習テキスト               
    Joint work
    Mar. 1999
  • 病院薬局製剤・第4版(日本病院薬剤師会偏)               
    Joint work
    Apr. 1997

Lectures, oral presentations, etc.

  • Aiming for an upgraded pain treatment: Formulation design and IC support for Tarlige OD tablets               
    Noriyuki Namiki
    02 Aug. 2025, [Invited]
  • Pharmaceutical Properties of Aripiprazole Gummy Formulations and Evaluation of Their Palatability in Healthy Volunteers               
    Shinya Uchida; Sayuri Kawamoto; Shimako Tanaka; Motoyasu Miura; Yasuharu Kashiwagura; Naoki Inui; Hiroshi Watanabe; Noriyuki Namiki
    The European Association for Clinical Pharmacology and Therapeutics EACPT2025 Helsinki, 01 Jul. 2025
  • Designing medication forms that can be considered "good partners in life"               
    Noriyuki Namiki
    07 Jun. 2025, [Invited]
  • 服薬アドヒアランス向上を目指した製剤設計               
    22 Dec. 2024, [Invited]
  • サムスカ(トルバプタン)OD錠(HybrIDTAB)の臨床的機能性               
    22 Sep. 2024, [Invited]
  • Visual analog scale-based evaluation of palatability of orally disintegrating tablets in healthy volunteers               
    Shinya Uchida; Motoyasu Miur; Seiki Kojima; Yasuharu Kashiwagur; Noriyuki Namiki
    The European Association for Clinical Pharmacology and Therapeutics EACPT2025 Helsinki, 10 Jun. 2024
  • Population pharmacokinetic analysis of drugs for pulmonary hypertension and estimation of plasma concentrations in pediatric and adult patients               
    Motoyasu Miura; Shimako Tanaka; Yasumi Nakashim; Yasuharu Kashiwagura; Mariko Tatsuguchi; Keiichi Odagiri; Noriyuki Namiki; Naoki Inui; Hiroshi Watanabe; Shinya Uchid
    The European Association for Clinical Pharmacology and Therapeutics EACPT2025 Helsinki, 10 Jun. 2024
  • アップグレードした疼痛治療を目指すタリージェOD錠の製剤設計               
    19 May 2024, [Invited]
  • Multi-Morbidityな超高齢者医療を見据えたDOAC-OD錠の臨床的機能性               
    17 Apr. 2024, [Invited]
  • アップグレードした疼痛治療を目指す-タリージェOD錠の製剤設計-               
    11 Nov. 2023, [Invited]
  • 腎臓病薬物療法における臨床的機能性製剤の設計コンセプト               
    28 Oct. 2023, [Invited]
  • アップグレードした疼痛治療を目指すータリージェOD錠の製剤設計ー               
    11 Jun. 2023, [Invited]
  • 苦い”くすり”を苦くない”くすり”にする製剤設計               
    05 Nov. 2022, [Invited]
  • OD錠の臨床的機能性が変える心不全治療薬の服薬アドヒアランス戦略               
    01 Nov. 2022, [Invited]
  • 臨床的機能性の観点からレミッチOD錠を検証する               
    09 Oct. 2022, [Invited]
  • 糖尿病患者の服薬不履行についてーその対策ー               
    18 Jun. 2022, [Invited]
  • 期待する治療効果を得るための服薬アドヒアランス新戦略               
    20 Jul. 2019, [Invited]
  • 服薬アドヒアランス向上を目指したピートルマイクロタブレット型の顆粒剤の臨床的機能性               
    30 Jun. 2019, [Invited]
  • 臨床的機能性を有する製剤の開発ー服薬アドヒアランス向上を目指して               
    14 Jun. 2019, [Invited]
  • 臨床的機能性を有する製剤の設計               
    20 Feb. 2019, [Invited]
  • 進化する医療現場で求められる製剤設計とは               
    19 Feb. 2019, [Invited]
  • IoT技術を活用した医薬品包装と遠隔診療のパラダイムシフト               
    31 Oct. 2018, [Invited]
  • IoT技術を活用した医薬品包装と遠隔診療のバラダイムシフト               
    31 Oct. 2018, [Invited]
  • IoT時代に即した脳梗塞薬物治療の新展開~更なる服薬アドヒアランスの向上を目指して~               
    17 Mar. 2018, [Invited]
  • IoT時代に即した脳梗塞薬物治療の新展開ー更なる服薬アドヒアランス向上を目指してー               
    26 Nov. 2017, [Invited]
  • IoT時代に即した脳梗塞薬物治療の新展開               
    21 Oct. 2017, [Invited]
  • OD錠の臨床的機能性とアドヒアランス               
    12 Oct. 2017, [Invited]
  • 医薬品製剤の臨床的機能性を向上させる包装技術               
    05 Oct. 2017, [Invited]
  • 抗凝固薬の服薬アドヒアランス向上を目指した剤形               
    17 Sep. 2017, [Invited]
  • 第26回千葉大学大学院薬学研究院薬友会生涯教育セミナー               
    08 Jul. 2017, [Invited]
  • DOAC-OD錠のBranding design が抗凝固療法に与えてきたSustainable な価値観               
    04 Jul. 2017, [Invited]
  • 脳卒中再発防止戦略に今こそパラダイムシフトが求められるとき               
    16 Mar. 2017, [Invited]
  • アドヒアランス向上を目指した臨床的機能性をもつ製剤の選択               
    04 Aug. 2016, [Invited]
  • 日本薬学会関東支部市民講座「くすりと健康2016春季講演会」               
    14 May 2016, [Invited]
  • 口腔内崩壊錠の臨床的機能性               
    10 Apr. 2016, [Invited]
  • 脳梗塞患者さんのアドヒアランス向上を目指した口腔内崩壊錠の飽くなき追求               
    27 Sep. 2015, [Invited]
  • 慶應義塾大学薬学部公開講座               
    04 Jul. 2015, [Invited]
  • 口腔内崩壊錠の進化の系譜               
    31 May 2015, [Invited]
  • 患者アドヒアランス向上の飽くなき追求               
    22 May 2015
  • 服薬アドヒアランス向上を目指した製剤開発の意義               
    28 Mar. 2015, [Invited]
  • 脳梗塞患者さんのアドヒアランス向上を目指した飽くなき追求               
    26 Mar. 2015, [Invited]
  • 口腔内崩壊錠の進化の系譜               
    18 Mar. 2015, [Invited]
  • アドヒアランス向上を目指した口腔内崩壊錠の臨床的機能性               
    22 Feb. 2015, [Invited]
  • 東京理科大学薬学部薬学講座講演会               
    18 Oct. 2014, [Invited]
  • 日本薬剤学会第29年会公開市民講演会               
    14 May 2014, [Invited]
  • 東邦大学薬学部生涯学習講座               
    01 Mar. 2010, [Invited]

Affiliated academic society

  • Jul. 1996 - Present
    日本薬剤学会               
  • Jan. 1981 - Present
    日本薬学会               
  • Feb. 1991
    日本医療薬学会               

Research Themes

  • 口腔内崩壊錠の服用性評価のための試験法確立とその応用               
    Apr. 2017 - Mar. 2020

Industrial Property Rights

  • 特願102106865, 「経口剤               
  • 特願PCT/JP2013/055043, 経口剤               
  • 特願2014-502272, 経口剤               
  • 特願2003-357803, 口腔内速崩錠               
  • 特願2002-302546, 口腔内速崩錠               
  • 特願2002-243722, 局所麻酔用固形状組成物               
  • 特願9-52850, グミ製剤               
  • 特願8-147575, グミ製剤               

Social Contribution Activities

  • 日本病院薬剤師会「病院薬局製剤」第6版編集委員               
    Sep. 2007 - Mar. 2008
  • 大規模生涯研修計画検討委員会委員(厚労省、日本薬剤師研修センター、教材作成WG)               
    Apr. 2006 - Mar. 2008
  • 日本病院薬剤師会生涯研修委員               
    Apr. 2006 - Mar. 2008
  • 東京都病院薬剤師会理事               
    Apr. 2006 - Mar. 2008
  • 日本病院薬剤師会広報委員               
    Apr. 2004 - Mar. 2008
  • 東京都病院薬剤師会教育研修部副部長               
    Apr. 2000 - Mar. 2008
  • 日本病院薬剤師会「病院薬局製剤」第5版編集委員               
    Sep. 2002 - Mar. 2003
  • 日本病院薬剤師会「病院薬局製剤」第4版編集委員               
    editor
    Sep. 1996 - Mar. 1997

Media Coverage

  • グミ感覚で摂取 新たな製剤開発               
    Jun. 2014, Paper
  • ロングセラー薬列伝-発売後25年が経過、今も進化し続ける抗血小板薬               
    Jan. 2014, Paper
  • 薬の飲みやすさが医療を変える ジュネリック医薬品に大きな期待               
    Jan. 2014, Paper
  • 「優しい薬」治療に効果               
    Feb. 2011
  • 患者に優しい薬 続々               
    Feb. 2011
  • 患者に優しい薬 続々、口の中ですぐ溶ける/異なる作用を配合               
    Feb. 2011
  • 患者に優しい薬続々 口腔内崩壊錠や配合薬               
    Feb. 2011
  • 患者に優しい薬 誤嚥防ぎ治療効果もアップ               
    Feb. 2011
  • 患者に優しい飲み薬続々 製薬会社、開発に本腰               
    Feb. 2011, Paper
  • 患者に優しい薬続々 製薬会社開発に本腰               
    Feb. 2011, Paper
  • 患者に”優しい”薬続々 各社、安全性や治療効果がアップ 各メーカー、開発に本腰               
    Jan. 2011, Paper
  • 脳梗塞慢性期における抗血小板療法の役割と服薬継続の重要性               
    Oct. 2010, Paper
  • 脳卒中慢性期管理における嚥下障害とOD錠の意義(薬剤師の立場から)               
    Apr. 2010, Paper
  • グミなど形状工夫 高齢者・子供への負担軽く               
    Feb. 1999, Paper
  • 「グミ薬」を開発 香料混ぜ苦みなく               
    Apr. 1995, Paper
  • お菓子のような解熱剤               
    Apr. 1995, Paper
  • フルーツ味の「グミ薬」開発中 クスリもおいしい時代へ               
    Apr. 1995
  • グミ薬 試作品が大好評 水なしでも食べられる               
    Apr. 1995, Paper
  • 患者に優しい薬 続々 各社               
    Media report

Academic Contribution Activities

  • PLCM研究会幹事               
    Apr. 2008 - Present
  • 日本薬剤学会第36年会最優秀発表者賞選考審査委員               
    May 2021 - May 2021
  • 日本薬剤学会第36年会(徳島)組織委員               
    May 2020 - May 2021
  • 日本薬剤学会第35年会(熊本)組織委員               
    May 2019 - May 2020
  • 日本薬剤学会第33年会(静岡)年会長               
    May 2018 - May 2018
  • 日本薬剤学会第33年会(静岡)組織委員長               
    May 2017 - May 2018
  • 日本薬剤学会理事               
    May 2008 - Apr. 2012
  • 日本薬剤学会会誌「薬剤学」投稿論文審査委員               
    Jan. 2008 - Dec. 2010
  • 日本薬剤学会ビジョン委員会委員               
    Apr. 2007 - Mar. 2008
  • 日本薬剤学会第22年会最優秀発表賞選考委員               
    Mar. 2007 - Mar. 2007
  • 日本薬剤学会役員評議員候補者選考委員               
    Review
    Apr. 2004 - Mar. 2007
  • 日本薬剤学会第21年会最優秀発表賞選考委員               
    Mar. 2006 - Mar. 2006
  • 日本薬剤学会製剤セミナー実行委員               
    Apr. 2002 - Mar. 2004
  • 日本薬学会ファルマシアトピックス小委員会               
    Apr. 1999 - Mar. 2002

■Achievement List

Award History

  • Jan. 2021
    Url

■University education and qualification information

Qualifications, licenses

  • 01 Jun. 1979
  • 01 Jul. 1999
  • 01 Jan. 2022
  • 01 Jan. 2022